Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis

NCT00345137 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

ADPKD
Glomerulonephritis

Interventions

DRUG: Ng-monomethyl-L-arginine (drug)

Sponsor

Regional Hospital Holstebro